CXO企业国内营收集体“首降” 五大龙头净利润全线下滑 拐点渐显至暗时刻已过?

新浪证券
03 Apr

2024年,中国CXO行业交出了一份并不理想的成绩单。药明康德、康龙化成、泰格医药、凯莱英、博腾股份五大头部企业净利润全线下滑。其中,药明康德营收、净利润分别同比下滑2.73%、1.37%,历史首次出现营收、利润双降;康龙化成归母净利润虽同比增长12.01%,但扣除非经常损益后则同比下滑26.82%,扣非净利润同为历史首次出现同比下滑;凯莱英净利润在2023年同比下降超30%的基础下进一步下探,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10